Congratulations to Ammira Akil and colleagues on the publication of their review article in Cells journal. Type 1 diabetes (T1D) is a serious and growing health issue, so new and innovative therapies are urgently needed. In this review, the authors take recent advances in knowledge of epigenetic factors in T1D and discuss how they can be applied therapeutically. A must-read for anyone in the diabetes and epigenetics fields, and a fascinating insight into the combination of these two research areas towards the development of novel T1D therapies.
Read the full article here: